News Analysis NIH Director Bhattacharya named acting CDC director in latest public health shakeupThe temporary appointment concentrates vast authority in the hands of one person February 20, 2026Vol.52 No.07By Claire Marie Porter
Black History MonthPodcast Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology“When it gets down to brass tacks, relationships between each other, we’re all one.” February 20, 2026Vol.52 No.07By Malcolm V. Brock, Robert A. Winn and Preston Willett
Guest Editorial Sustaining community oncology through nonprofit structures and shared technology infrastructure February 20, 2026Vol.52 No.07By Jacob Welkley
Guest Editorial California Institute of Regenerative Medicine and Cancer Research: A promise broken? February 20, 2026Vol.52 No.07By Stephen J. Forman
Sponsored Rewriting immune regulation with the CD6/CTLA‑4 CAR‑Treg platform February 20, 2026Vol.52 No.07By Christine Brown and Enrique Montero
NCI The FY26 funding package gave NCI a raise, but the institute’s buying power is 18% less than it was two decades agoLowy: “We still have percentiles, but we’re not allowed to make awards exclusively on the basis of payline.” February 13, 2026Vol.52 No.06By Jacquelyn Cobb
Regulatory News CBER Director Vinay Prasad sidelined staff to jettison Moderna’s mRNA flu shot February 13, 2026Vol.52 No.06By Claire Marie Porter
Black History MonthCancer History ProjectFree Olopade: “The genetic basis of every cancer, or everything we do, starts in Africa.”For Black History Month, Olopade reflects on mentorship, community, and her career in cancer genetics February 13, 2026Vol.52 No.06By Olufunmilayo I. Olopade, Robert A. Winn and Preston Willett
NCI NCAB ad hoc group approves seven new, reissue concepts February 13, 2026Vol.52 No.06By Sara Willa Ernst
FreeGuest Editorial Science is winning the war on cancer—CMS shouldn’t disarm February 13, 2026Vol.52 No.06By John M. O’Brien
